Medical News

---

• Perfusion defects common following PE
• Thrombolysis contraindications ‘should be re-evaluated’
• Clinical course of guttate psoriasis generally good
• Metformin does not improve outcomes in diabetics after radical prostatectomy
• Pulmonary metastasectomy may prolong breast cancer survival
• Metformin does not improve outcomes in diabetics after radical prostatectomy
• Non-HDL cholesterol better than total cholesterol at predicting Japanese AMI
• Long-term trial results ‘support intensive lipid control’
• Patients with COPD and diabetes have increased in hospital mortality
• Exenatide treatment could be useful for weight loss in nondiabetic obese
• Evidence-based ACS treatment options assessed for survival benefit
• Gene variants may influence NSAID-induced coronary risk
• Pulmonary metastasectomy may prolong breast cancer survival

Perfusion defects common following PE Posted: 17 Jun 2010 05:00 PM PDT Almost a third of patients show pulmonary perfusion defects 1 year after pulmonary embolism, say French researchers who identified key clinical risk factors for this outcome.

Thrombolysis contraindications ‘should be re-evaluated’ Posted: 17 Jun 2010 05:00 PM PDT Outcomes after stroke thrombolysis are no worse if patients have contraindications, based on current licensing restrictions, than if they have none, suggests a large Finnish study.

Clinical course of guttate psoriasis generally good Posted: 17 Jun 2010 05:00 PM PDT Study results indicate that guttate psoriasis tends to have a better prognosis than other types of psoriasis, but researchers warn that progression of the guttate form of psoriasis into the chronic plaque form is not uncommon.

Metformin does not improve outcomes in diabetics after radical prostatectomy Posted: 17 Jun 2010 05:00 PM PDT Research results show that metformin use does not protect men with diabetes from the risk for biochemical recurrence after radical prostatectomy for prostate cancer.

Pulmonary metastasectomy may prolong breast cancer survival Posted: 17 Jun 2010 05:00 PM PDT Pulmonary metastasectomy is a reasonable treatment option for patients with breast cancer and a limited number of isolated lung metastases, study findings indicate.

Metformin does not improve outcomes in diabetics after radical prostatectomy Posted: 17 Jun 2010 05:00 PM PDT Research results show that metformin use does not protect men with diabetes from the risk for biochemical recurrence after radical prostatectomy for prostate cancer.

Non-HDL cholesterol better than total cholesterol at predicting Japanese AMI Posted: 17 Jun 2010 05:00 PM PDT The risk for acute myocardial infarction in Japanese individuals can be more reliably predicted from serum levels of non-high-density lipoprotein cholesterol than total cholesterol, researchers report.

Long-term trial results ‘support intensive lipid control’ Posted: 17 Jun 2010 05:00 PM PDT The longest follow-up of a lipid-atherosclerosis intervention trial to date supports the longevity benefits of intensive intervention to control lipid levels, say researchers.

Patients with COPD and diabetes have increased in hospital mortality Posted: 17 Jun 2010 05:00 PM PDT Patients who are hospitalized for an acute exacerbation of chronic obstructive pulmonary disease who also have diabetes have higher in hospital mortality and are likely to be hospitalized for longer than nondiabetics, say researchers

Exenatide treatment could be useful for weight loss in nondiabetic obese Posted: 17 Jun 2010 05:00 PM PDT Exenatide treatment plus lifestyle modification is effective for promoting weight loss and improving glucose tolerance in nondiabetic and prediabetic obese individuals, show study results.

Evidence-based ACS treatment options assessed for survival benefit Posted: 17 Jun 2010 05:00 PM PDT The use of multiple evidence-based therapies for acute coronary syndromes is associated with diminishing returns, with coronary revascularization offering the most robust 6-month survival advantage, study results indicate.

Gene variants may influence NSAID-induced coronary risk Posted: 17 Jun 2010 05:00 PM PDT Variants in the prostaglandin-endoperoxide synthase-1 and C-reactive protein genes may influence the risk for acute coronary events associated with non-steroidal antiinflammatory drugs, Canadian researchers believe.

Pulmonary metastasectomy may prolong breast cancer survival Posted: 17 Jun 2010 05:00 PM PDT Pulmonary metastasectomy is a reasonable treatment option for patients with breast cancer and a limited number of isolated lung metastases, study findings indicate.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610